Fact Source: Financial Supervisory Service DART / 2025-12-16
Disclosure Type: Setting of Record Date or Closure of Shareholders’ Register
💡 3-Second Summary
Samsung Biologics has announced December 31, 2025, as the record date to determine shareholders entitled to vote at the 15th Annual General Meeting. The company will temporarily close its share registry (suspension of entry changes) from January 1, 2026, to January 31, 2026.
📊 1. [Key Disclosure Content & Major Figures Summary]
- Record Date: 2025-12-31
- Share Registry Closure (Suspension of Entry Changes) Period: Start Date: 2026-01-01 ~ End Date: 2026-01-31 (For 1 month)
- Reason for Setting: Determination of eligible shareholders with voting rights for the upcoming 15th Annual General Meeting of Shareholders.
- Other Details: No separate references for investment decisions are provided in the disclosure text. As this filing is intended solely for administrative routine guidance, specific financial figures or drivers behind earnings fluctuations are not provided.
📈 2. [Expert View: What This Disclosure Means for Investors]
This regulatory filing details a standard administrative measure issued by Samsung Biologics to define the eligible shareholder perimeter for the upcoming 15th AGM. While it does not contain direct adjustments to corporate fundamentals, contract wins, or cross-border CAPEX updates, it serves as an essential procedural fact establishing the baseline corporate calendar.
Investors should note that individuals registered on the share ledger exactly as of the record date (December 31, 2025) will be granted statutory voting rights regarding upcoming AGM agendas. During the closure window from January 1 to January 31, 2026, modifications to the share registry will be restricted. Because no structural parameters regarding actual performance or proposed agendas are verified through this text, investors should avoid drawing short-term directional conclusions. Instead, this filing should be treated as a programmatic anchor to prepare for monitoring subsequent convening notices, which will clarify final AGM dates and governance alignments.
📝 Editor’s Comment (by K-STOCK Editor)
The setting of the record date and share registry closure by Samsung Biologics represents a routine regulatory step framing the pre-AGM administrative phase. Locking the shareholder list as of the end of December 2025 and suspending register changes through January 2026 ensures an organized framework to determine voting eligibility. Because this filing functions strictly as an operational calendar notification without embedded balance sheet numbers or agenda details, immediate fundamental implications remain limited. Long-term investors should use this filing merely as a chronological marker and await the formalized general meeting convening notices to review specific upcoming resolutions and executive appointments.
📢 Disclaimer & Source Information
Source: This content has been newly structured and written based on official data submitted to the Financial Supervisory Service’s Electronic Disclosure System (DART).
Investment Risk Notice: This information is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the individual investor.
Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.
🔥 Bulls vs Bears, drop your analysis in the comments!
